Bayer AG raised its annual profit outlook after demand for some newer drugs drove a better-than-expected performance at its pharmaceutical unit.
Bayer AG raised its annual profit outlook after demand for some newer drugs drove a better-than-expected performance at its pharmaceutical unit.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)